About NovoBliss
NovoBliss is a company based in Gandhinagar (India) founded in 2021 by Nayan Patel and Maheshvari Patel. It operates as a B2B. The company has 18 employees as of March 31, 2022. NovoBliss offers products and services including Regulatory Consultancy, Clinical Services, Biostatistics and Programming, Medical Writing, and Medical Review. NovoBliss operates in a competitive market with competitors including WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
- Headquarter Gandhinagar, India
- Employees 18 as on 31 Mar, 2022
- Founders Nayan Patel, Maheshvari Patel
-
Sectors
HealthcareConsumer
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Novobliss Research Private Limited
- Date of Incorporation 05 Oct, 2021
- Jurisdiction Daskroi, Gujarat, India
-
Annual Revenue
$33.9 K (USD)0as on Mar 31, 2022
-
Net Profit
$1.88 K (USD)0as on Mar 31, 2022
-
EBITDA
$4.55 K (USD)0as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
18
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NovoBliss
NovoBliss offers a comprehensive portfolio of products and services, including Regulatory Consultancy, Clinical Services, Biostatistics and Programming, Medical Writing, and Medical Review.
Provides advice on regulatory compliance for health products
Conducts trials for cosmetics and nutraceuticals
Offers statistical analysis for clinical studies
Prepares reports and documents for health research
Performs evaluations for clinical and therapeutic studies
Funding Insights of NovoBliss
Detailed funding history for NovoBliss
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NovoBliss
Investment portfolio details for NovoBliss
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NovoBliss
Detailed financials for NovoBliss
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Novobliss Comparisons
Peer comparison for NovoBliss
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NovoBliss
NovoBliss operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of CRO and CDMO services
|
|
| Locked | Locked | Locked |
Laboratory testing and contract research services are provided globally.
|
|
| Locked | Locked | Locked |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| Locked | Locked | Locked |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| Locked | Locked | Locked |
Advisory, scientific, and medical communications provided for pharmaceutical industry.
|
|
| Locked | Locked | Locked |
Regulatory support, brand differentiation, and prototyping services are provided.
|
Detailed competitors of NovoBliss
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Novobliss
Complete news archive for NovoBliss
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NovoBliss
NovoBliss was founded in 2021.
NovoBliss is headquartered in Gandhinagar, India. It is registered at Gandhinagar, Gujarat, India.
Nayan Patel is the current CEO of NovoBliss. They have also founded this company.
As of Mar 31, 2022, the latest employee count at NovoBliss is 18.
Annual revenue of NovoBliss is $33.9K as on Mar 31, 2022.
NovoBliss is a company based in Ahmedabad, India, that specializes in clinical research services, regulatory consultancy, and medical writing. They conduct trials for cosmetics, nutraceuticals, and therapeutic products, ensuring compliance and quality. Working with global clients, they advance innovation in health sciences through expert teams and partnerships, focusing on areas like biostatistics and laboratory testing.
NovoBliss's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
NovoBliss offers Regulatory Consultancy, Clinical Services, Biostatistics and Programming, Medical Writing, and Medical Review.